2. UroToday Home
  3. Video Lectures

AUA 2022

Integration of Lutetium into Clinical Practice: A Urologist's Perspective - Neal Shore
June 20, 2023
Details
The Importance of Proper Transurethral Resection of Bladder Tumors (TURBT) in Bladder Cancer Treatment - Arnulf Stenzl
April 10, 2023
Details
Women in Urologic Oncology: Past, Present, and Future - Alicia Morgans & Sam Chang
February 28, 2023
Details
The Use of Genomics in Unfavorable Intermediate-risk Prostate Cancer - David Morris
December 20, 2022
Details
The Molecular Biology of Prostate Cancer - Christopher Barbieri
October 28, 2022
Details
Timing of Radical Cystectomy in BCG Unresponsive Disease - Patrick Hensley
October 17, 2022
Details
Women in Urologic Oncology - Anne K. Schuckman
October 17, 2022
Details
Bladder Cancer Highlights - Stephen Williams
October 16, 2022
Details
A Multidisciplinary Approach to Treating High-Grade Upper Tract Disease - A Case-Based Approach - Surena Matin, Jonathan Coleman, and Jean Hoffman-Censits
September 29, 2022
Details
Antegrade Administration of Reverse Thermal Mitomycin Gel for Primary Chemoablation of Upper Tract Urothelial Carcinoma via Percutaneous Nephrostomy Tube - Katie Murray
September 29, 2022
Details
Comparison of Dual Lumen Versus Single Lumen Flexible Ureteroscopes in Proximal Ureteral and Renal Stone Management - Rohit Bhatt
September 5, 2022
Details
Thermal Effects of the Super-Pulse Thulium Fiber Laser During Ureteral Stone Laser Lithotripsy: An In Vivo Porcine Study - Kalon Morgan
August 27, 2022
Details
Automated CT-based Stone Volume Determination: An Artificial Intelligence Algorithm to Calculate Kidney Stone Volume - Kalon Morgan
August 26, 2022
Details
Comparison of Superpulse Thulium Fiber Laser vs. Holmium Laser for Ablation of Renal Calculi in an In Vivo Porcine Model - Andyshea Afyouni
August 26, 2022
Details
A Probing Conversation on Prostate Cancer Diagnosis and the Potential of Liquid Biopsies and Polygenic Risk Scores - Sanoj Punnen
August 24, 2022
Details
The Controversy Over Radical Cystectomy for N1 and N2 Bladder Cancer: Experts Weigh In - Brant Inman & Yair Lotan
August 24, 2022
Details
Upper Tract Urothelial Carcinoma Highlights - Nima Almassi
August 14, 2022
Details
Adjuvant Treatment for Men with Prostate Cancer with High Risk of Metastasis, the ERADICATE Study - Ashley Ross
August 7, 2022
Details
Gender Differences in Bladder Cancer - Lauren Cooley
August 2, 2022
Details
Adjuvant Therapy after Nephroureterectomy for High-Risk Upper Tract Urothelial Carcinoma - Sima Porten
July 14, 2022
Details
Integrating 177Lu-PSMA-617 in Clinical Practice - Oliver Sartor
July 4, 2022
Details
Incorporating Genomic Testing for Prostate Cancer into Your Practice - Daniel Lin
June 24, 2022
Details
Why Not Biopsy? Challenging the Status Quo in Renal Mass Management - Jaime Landman
June 21, 2022
Details
From Ultrasound to AI: Envisioning the Future of Stone Disease Treatment - Ralph Clayman
June 21, 2022
Details
NCCN Guidelines Update on Selection of PSMA PET Imaging Agent in Patient Selection for Lutetium-177–PSMA-617 - Oliver Sartor
June 16, 2022
Details
BCG Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer - Seth Lerner
June 14, 2022
Details
Treatment of Unfavorable Intermediate Risk Prostate Cancer - Ashley Ross, Jason Hafron, and Katie Murray
June 14, 2022
Details
Mental Health and Impact on Patients with GU Malignancies - Zachary Klaassen
June 14, 2022
Details
The Importance of Multidisciplinary Collaboration in Urology Clinics - Neal Shore
June 8, 2022
Details
AUA Guidelines on Localized Prostate Cancer - Stephen Boorjian & James Eastham
June 3, 2022
Details
Prostate Volume, Baseline Urinary Symptoms, and Their Association with Treatment Choice and Post-Treatment Urinary Function in Men with Localized Prostate Cancer, The CEASAR Study - Daniel Barocas
June 2, 2022
Details
Early Triplet Combination Therapy Shows Increased Overall Survival: The ARASENS Trial - Tomasz Beer
May 24, 2022
Details
New Orleans Restaurant Favorites - Plan Your AUA 2022 Dining Experiences - Oliver Sartor
April 22, 2022
Details
Practice Changing Data from ARASENS - Statistically Significant Overall Survival - Fred Saad, Bertrand Tombal, and Neal Shore
March 23, 2022
Details
ARASENS Trial Significantly Improves Overall Survival with Darolutamide in Combination with ADT and Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer - Matthew Smith
March 11, 2022
Details
Darolutamide and Survival in Metastatic Hormone-Sensitive Prostate Cancer - ARASENS Trial - Karim Fizazi
February 24, 2022
Details